Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01473550
Other study ID # 18451
Secondary ID
Status Completed
Phase N/A
First received November 14, 2011
Last updated March 4, 2016
Start date November 2011
Est. completion date June 2014

Study information

Verified date March 2016
Source Lawson Health Research Institute
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

Patients with mood disorder or psychotic disorder will be given handheld devices with personal health records to educate, monitor and deliver customizable healthcare tools based on their personal needs. The use of technology has great potential to deliver care more effectively and efficiently. No actual information is on the handheld device - it is accessed from a secure site behind hospital firewalls.


Recruitment information / eligibility

Status Completed
Enrollment 400
Est. completion date June 2014
Est. primary completion date June 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Must be diagnosed with mood disorder or psychotic disorder for a minimum one year

- Able to make informed consent to participate in the study

- Able to understand and speak English to the degree necessary to participate in interviews/focus groups

Exclusion Criteria:

- Younger than 18 or older than 80

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Intervention

Behavioral:
Access to TELUS Health Space and Smart Phone
Participants will be given their own TELUS Health Space and Smart Phone in order to have access to their personal health records. Specific procedures using the smart phone will depend on the individual care plan for each participant. Prompts and assessments will vary depending on participant needs.

Locations

Country Name City State
Canada Canadian Mental Health Association (London-Middlesex Branch) London Ontario
Canada London Health Sciences Centre London Ontario
Canada Regional Mental Health Care London Ontario
Canada Western Ontario Therapeutic Community Hostel London Ontario

Sponsors (4)

Lead Sponsor Collaborator
Lawson Health Research Institute Canadian Mental Health Association, London Health Sciences Centre, St. Joseph's Health Care London

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Lehman Quality of Life - Brief Version Every 6 months for total of 18 months No
See also
  Status Clinical Trial Phase
Completed NCT00001919 - Neuroimaging of St. John's Wort-Induced Changes of Serotonin Metabolism in Normal Subjects N/A
Completed NCT00026832 - Examination of Brain Serotonin Receptors in Patients With Mood Disorders
Terminated NCT01830088 - Family Based Treatment of Depressed Adolescents (AHUS) N/A
Completed NCT01951508 - Effects of Methylphenidate, Modafinil, and MDMA on Emotion-processing in Humans: A Pharmaco-fMRI Study Phase 0
Completed NCT01269710 - Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study N/A
Completed NCT00001146 - Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial Phase 2
Completed NCT00001170 - Study of the Psychological Development of Children of Parents With and Without Affective Disorders N/A
Completed NCT00001192 - Neuropsychological Evaluation of Psychiatric and Neurological Patients N/A
Completed NCT02189057 - A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression N/A
Completed NCT00990067 - Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Phase 1
Completed NCT00794040 - A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation Phase 2
Completed NCT02819986 - Effectiveness of Using the Progressive Goal Attainment Program in Anxiety and Mood Disorders N/A
Completed NCT03538860 - Validation of an Automated Online Language Interpreting Tool - Phase Two. N/A
Completed NCT00016731 - Adolescence, Puberty, and Emotion Regulation
Completed NCT02721316 - Outpatient Nurse Monitoring Under the Prevention of Recurrent Suicidal N/A
Recruiting NCT02443636 - The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Registry
Terminated NCT01493323 - Functional Imaging of Psychic Pain N/A
Completed NCT00699218 - A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Bipolar Depression N/A
Completed NCT00001654 - The Role of Emotion in the Development of Psychopathology N/A
Completed NCT00001545 - Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders Phase 2